ATP7B and Wilson disease: In theory, a consistent mutation spectrum would be useful in making the pre-symptomatic diagnosis for WD patients; however, due to the large variability in ATP7B mutation and gene heterozygocity, it is difficult to utilize the mutation signatures as a diagnostic tool [44].